Important contents and patient medication instructions in the official package insert of Trelagliptin

Trelagliptin (Trelagliptin) is a new dipeptidyl peptidase-4 (DPP-4) inhibitor, mainly used for blood sugar management in patients with type 2 diabetes. According to the official instructions, the drug works by prolonging glucagon-like peptide-1 (GLP-1) and glucose-dependent insulin otropicThe action time of otropicpolypeptide (GIP) in the body promotes insulin secretion and inhibits glucagon release, thereby helping to reduce postprandial and fasting blood sugar. Compared with traditional DPP-4 inhibitors, trolagliptin has the advantage of being administered orally once a week, which improves patients' medication compliance.

In terms of indications, trolagliptin is mainly used for patients with type 2 diabetes who have poor blood sugar control. It can be used as a single drug or in combination with metformin, sulfonylureas or insulin. During use, patients should regularly monitor blood sugar, glycated hemoglobin (HbA1c), and liver and kidney function to ensure efficacy and safety. According to the instructions, patients with renal insufficiency do not need to adjust the dosage, but should use it under the guidance of a doctor and pay close attention to potential adverse reactions.

The official instructions also have clear tips on safety. The adverse reactions of trolagliptin are generally mild, and common ones include headache, diarrhea and nasopharyngitis. In rare cases, symptoms of allergic reaction or pancreatitis may occur, such as persistent abdominal pain, nausea, vomiting, etc. You should stop taking the drug immediately and seek medical treatment. In addition, patients should pay attention to the risk of hypoglycemia during use, especially when combined with sulfonylureas or insulin, and should adjust the dose reasonably and closely observe blood sugar changes.

In terms of patient medication guidance, trolagliptin should be taken orally once a week at a fixed time and can be taken with food or on an empty stomach, but missed doses should be avoided. If you miss a dose, you should take it as soon as possible, but do not take a double dose at one time. Patients should maintain a balanced diet and regular exercise during use, and regularly review blood sugar and related indicators. Following the doctor's instructions and instructions can maximize the efficacy of trolagliptin, while reducing the risk of adverse reactions and helping patients better control blood sugar and manage diabetes.

Reference link:https://www.drugs.com